The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index; none of the 216 sources its claims cite is checked for support yet.
Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia.
Open accessAbstract
Influenza and other respiratory viral infections are the most common type of acute respiratory infection. Viral infections predispose patients to secondary bacterial infections, which often have a more severe clinical course. The mechanisms underlying post-viral bacterial infections are complex, and include multifactorial processes mediated by interactions between viruses, bacteria, and the host immune system. Studies over the past 15 years have demonstrated that unique microbial communities reside on the mucosal surfaces of the gastrointestinal tract and the respiratory tract, which have both direct and indirect effects on host defense against viral infections. In addition, antiviral immune responses induced by acute respiratory infections such as influenza are associated with changes in microbial composition and function ("dysbiosis") in the respiratory and gastrointestinal tract, which in turn may alter subsequent immune function against secondary bacterial infection or alter the dynamics of inter-microbial interactions, thereby enhancing the proliferation of potentially pathogenic bacterial species. In this review, we summarize the literature on the interactions between host microbial communities and host defense, and how influenza, and other acute respiratory viral infections disrupt these interactions, thereby contributing to the pathogenesis of secondary bacterial infections.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes evidence that acute respiratory viral infections—especially influenza—induce dysbiosis in the gut and respiratory tract microbiomes, which in turn alters host immune priming and inter-microbial competition, contributing to secondary bacterial pneumonia. It argues that these microbiome shifts are driven largely by systemic antiviral immune signals rather than direct viral presence at distant sites.
Key findings
- Respiratory viral infection alters the gut microbiome despite no detectable virus in the GI tract: murine influenza models show reduced segmented filamentous bacteria and Lactobacillus/Lactococcus with increased Enterobacteriaceae/Proteobacteria, effects mediated by type I and type II interferons and possibly by reduced caloric intake.
- Viral infection is associated with increased colonization by potential pathogens in the upper respiratory tract: in adults with influenza A, *S. aureus*, *S. pneumoniae*, and *H. influenzae* were present in 12%, 24%, and 32% of infected patients versus 5%, 11%, and 10% of uninfected patients; in children, influenza was associated with a 15-fold increase in nasopharyngeal *S. pneumoniae* titer.
- In a mouse model, intranasal live attenuated influenza vaccine increased nasopharyngeal bacterial density up to 100,000-fold and prolonged *S. pneumoniae* or *S. aureus* carriage 2- to 5-fold.
- Gut microbiome depletion (antibiotics or germ-free status) impairs antiviral and antibacterial immunity—reduced antibody and CD4+/CD8+ T cell responses, defective macrophage IFN responses, decreased phagocytosis and TNF-α—while commensal re-colonization (e.g., *Lactobacillus reuteri*, *Enterococcus faecalis*, *Lactobacillus crispatus*, *Clostridium orbiscindens*) protected against bacterial pneumonia via GM-CSF.
- Inter-microbial competition matters: nasal implantation of a *Corynebacterium* strain eradicated *S. aureus* in 71% of persistent carriers, and *C. accolens* inhibits *S. pneumoniae* growth in vitro via a lipase releasing free fatty acids.
Methods
- Narrative literature review (not a primary study) covering human and animal studies on gut and respiratory tract microbiomes during respiratory viral infection, with a stated focus on the bacterial microbiome because of a paucity of mycobiome and virome studies.
- Synthesizes cross-sectional and longitudinal human studies (16S rRNA sequencing, qPCR, metagenomics, culture-independent pyrosequencing) alongside murine, ferret, and in vitro models, organized by anatomic niche (gut, URT, LRT) and by mechanism (host immune effects, inter-microbial effects, direct viral effects on bacteria).
- No systematic search strategy, inclusion criteria, or quantitative synthesis is reported.
Limitations
- Stated by the paper: protocols for sampling, processing, and bioinformatics of the respiratory microbiome are not standardized; most studies are in animal models, and human studies are small and largely limited to the URT; fungi and viruses (including phages) are largely omitted because 16S rRNA analysis cannot capture them; species-composition studies are insufficient without functional transcriptomic/proteomic characterization; long-term effects of microbiome-modulating therapies (especially antibiotics) are unknown.
- Stated by the paper: cross-sectional human studies are poorly controlled and small relative to confounding variables (age, gender, oral hygiene, smoking, medication, healthcare employment, exposure to children), and are confounded by viral type, sampling timing, infection severity, and antimicrobial use.
- Evident from the text: the central mechanistic claim—that viral-induced microbiome changes cause secondary bacterial pneumonia in humans—is explicitly described as not yet examined ("the effects of these alterations on risk of secondary bacterial pneumonia have not been studied"), and much of the supporting evidence is from murine models under SPF conditions that may not reflect more diverse human or wild-mouse microbiota.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 216 cited sources checked · 0 supported · 0 flagged
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“antiviral immune responses induced by acute respiratory infections such as influenza are associated with changes in microbial composition and function (“dysbiosis”) in the respiratory and gastrointestinal tract”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Influenza and other respiratory viral infections predispoxsse patients to secondary bacterial super-infections”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“which have both direct and indirect effects on host defense against viral infections”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“over half of patients with severe infections in the 1957 H2N2 and 1968 H3N2 pandemics had bacterial complications”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
What the sources say
- Not checked yetcites [8] Bisno, 1971, Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic, Am J Med Sci source
- Not checked yetcites [9] Hers, 1958, Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza, Lancet source
- Not checked yetcites [10] Oswald, 1958, Pneumonia complicating Asian influenza, Br Med J source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“influenza infection has been found to result in significant changes in the gut microbiome, despite the lack of detectable virions in the GI tract”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearNone of the sources cited for this claim have been checked yet.
In the paper
“The severity of infection was associated with reductions in dendritic cell migration rate and the number of local T cells.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“flu-infected mice had increased IL-17A levels and numbers of Th17 cells in the small intestine and colon, which appeared to contribute to intestinal injury”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of acute respiratory viral infection on gut microbiome
What the sources say
- Not checked yetcites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“influenza infection alters intestinal microbiota composition through type II IFN produced by lung-derived T cells recruited to the intestine”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of acute respiratory viral infection on gut microbiome
What the sources say
- Not checked yetcites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“These mice also had higher viral titers in their lungs”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
- Not checked yetcites [51] Ichinohe, 2011, Microbiota regulates immune defense against respiratory tract influenza A virus infection, Proc Natl Acad Sci USA source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“During viral infections, the degree of macrophage response to respiratory viruses depends on the presence of gut microbes.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 68
- Probably not a substantial claim. 38
None of the sources cited for this claim have been checked yet.
In the paper
“Bacterial co-infection was also detected in ~30% of cases in the 2009 H1N1 pandemic, with high mortality rates despite administration of appropriate antibiotics”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
What the sources say
- Not checked yetcites [11] Cillóniz, 2012, Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia, J Infect source
- Not checked yetcites [12] Gill, 2010, Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections, Arch Pathol Lab Med source
- Not checked yetcites [13] Jain, 2009, Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009, N Engl J Med source
- Not checked yetcites [14] Kumar, 2009, Critically ill patients with 2009 influenza A(H1N1) infection in Canada, JAMA source
- Not checked yetcites [15] Martín-Loeches, 2011, Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus, Chest source
- Not checked yetcites [16] Palacios, 2009, Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza, PLoS ONE source
- Not checked yetcites [17] Shieh, 2010, 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States, Am J Pathol source
- Not checked yetcites [18] Domínguez-Cherit, 2009, Critically Ill patients with 2009 influenza A(H1N1) in Mexico, JAMA source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which in turn may alter subsequent immune function against secondary bacterial infection or alter the dynamics of inter-microbial interactions, thereby enhancing the proliferation of potentially pathogenic bacterial species”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the so-called “Spanish Flu” pandemic of H1N1 influenza A virus from 1918 to 1919 resulted in more than 50 million deaths, with many caused by bacterial super-infection leading to secondary pneumonia”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
What the sources say
- Not checked yetcites [1] Brundage, 2006, Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness, Lancet Infect Dis source
- Not checked yetcites [2] Chien, 2009, Bacterial pathogens and death during the 1918 influenza pandemic, N Engl J Med source
- Not checked yetcites [3] Johnson, 2002, Updating the accounts: global mortality of the 1918-1920 “Spanish” influenza pandemic, Bull Hist Med source
- Not checked yetcites [4] McCullers, 2006, Insights into the interaction between influenza virus and pneumococcus, Clin Microbiol Rev source
- Not checked yetcites [5] Morens, 2007, The 1918 influenza pandemic: insights for the 21st century, J Infect Dis source
- Not checked yetcites [6] Morens, 2008, Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness, J Infect Dis source
- Not checked yetcites [7] The origin and virulence of the 1918 “Spanish” influenza virus86112 TaubenbergerJK 17526158Proc Am Philos Soc1502006
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“which often have a more severe clinical course”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Abstract
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“unique microbial communities reside on the mucosal surfaces of the gastrointestinal tract and the respiratory tract”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Abstract
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mechanisms underlying post-viral bacterial infections are complex, and include multifactorial processes mediated by interactions between viruses, bacteria, and the host immune system.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“microbial metabolites are integral for promoting immune responses in the gut against pathogens, including inducing secretion of IL-18 (36) and defensins (37, 38)”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
What the sources say
- Not checked yetcites [36] Kalina, 2002, Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region, Eur J Immunol source
- Not checked yetcites [37] Schauber, 2003, Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways, Gut source
- Not checked yetcites [38] Schauber, 2004, Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells, Mol Immunol source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“SCFAs promote the development of naive CD4+ T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
What the sources say
- Not checked yetcites [31] Smith, 2013, The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis, Science source
- Not checked yetcites [32] Arpaia, 2013, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, Nature source
- Not checked yetcites [33] Goverse, 2017, Diet-derived short chain fatty acids stimulate intestinal epithelial cells to induce mucosal tolerogenic dendritic cells, J Immunol source
- Not checked yetcites [34] Mariño, 2017, Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes, Nat Immunol source
- Not checked yetcites [35] Haase, 2018, Impacts of microbiome metabolites on immune regulation and autoimmunity, Immunology source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“potential mechanisms by which these changes might modulate susceptibility to secondary bacterial infections include alterations in the nature and magnitude of the immune response in the host (microbiome on host effects) and facilitating growth of pathogens in the absence of normal commensals (inter-microbial effects)”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Germ-free (GF) mice (which lack microbiota) have markedly underdeveloped gut-associated lymphoid tissues, decreased number and smaller-sized Peyer's patches and mesenteric lymph nodes, and defects in antibody production, compared to specific pathogen free (SPF) mice.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Wild-living mice exhibit more diverse microbiomes, with significant abundance of Proteobacteria as well as Firmicutes and Bacteroidetes”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
What the sources say
- Not checked yetcites [21] Rosshart, 2017, Wild mouse gut microbiota promotes host fitness and improves disease resistance, Cell source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“While the effects of these alterations on risk of secondary bacterial pneumonia have not been studied”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“germ-free animals exhibit increased susceptibility to multiple types of infections, including viruses, bacteria, and parasites”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
What the sources say
- Not checked yetcites (22,–27)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate are fermentation products of dietary fiber and carbohydrates by large intestinal bacteria”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
What the sources say
- Not checked yetcites [30] Cummings, 1983, Fermentation in the human large intestine: evidence and implications for health, Lancet source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This raises the possibility that disruptions in the normal microbial communities by an acute viral infection might contribute to the development of post-viral bacterial pneumonia.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“During health, the human gut bacterial community is diverse, with each individual harboring over 100 trillion bacteria, comprised of over 150 different species.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The gastrointestinal microbiota is dominated by Firmicutes (e.g., Lactobacillus, Bacillus, and Clostridium) and Bacteroidetes (e.g., Bacteroides), with lower abundances of Proteobacteria (e.g., Escherichia) and Actinobacteria (e.g., Bifidobacterium)”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“segmented filamentous bacteria are critical promoters of intestinal mucosal IgA production (39, 40)and Th17 cell induction (41, 42)”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
What the sources say
- Not checked yetcites [39] Klaasen, 1993, Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice, Infect Immun source
- Not checked yetcites [40] Talham, 1999, Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system, Infect Immun source
- Not checked yetcites [41] Ivanov, 2009, Induction of intestinal Th17 cells by segmented filamentous bacteria, Cell source
- Not checked yetcites [42] Gaboriau-Routhiau, 2009, The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses, Immunity source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The gut microbiome, in particular, has been shown to play an integral role in shaping the immune system starting early in life, with continued influence on priming the nature and robustness of immune responses throughout one's lifetime.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“compared to free-living mice or laboratory animals exposed to gut flora from wild mice, SPF animals have a more limited microbial community and are also more susceptible to inflammatory diseases, with a reduced immune repertoire including deficits in memory responses”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
What the sources say
- Not checked yetcites [21] Rosshart, 2017, Wild mouse gut microbiota promotes host fitness and improves disease resistance, Cell source
- Not checked yetcites [28] Reese, 2016, Sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response, Cell Host Microbe source
- Not checked yetcites [29] Beura, 2016, Normalizing the environment recapitulates adult human immune traits in laboratory mice, Nature source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“emerging evidence suggests that our microbial communities residing on our mucosal surfaces likely shape the rigor of our immune responses and shape the ecological relationships between host and pathogens”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“bacterial metabolites generated by gut commensals contribute to the maintenance of intact epithelial integrity, regulatory T-cell development, and a relatively anti-inflammatory immune state”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The pathogenesis of super-infection has been attributed to direct mucosal/epithelial damage by influenza virus, increased bacterial colonization of the upper and lower respiratory tracts (URT and LRT, respectively), and dysregulation of immune responses, which all lead to increased susceptibility to secondary bacterial infections.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“the effects of viral infection on the respiratory microbiome appear to be relatively modest, but detectable”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The respiratory tract also harbors distinct communities of microbes, with multiple discrete ecological niches (e.g., nasal cavity, oropharynx, upper airways) that vary in terms of temperature, pH, oxygen tension, mucus production, and other factors.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Introduction
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The gut microbiome, in addition to its metabolic functions in the host, plays an integral role in the development, instruction, and priming of the immune system.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The increase in Proteobacteria appears to be mediated by type I interferons (IFNs) (18), which not only depleted anaerobic bacteria but also increased susceptibility to secondary Salmonella colitis.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of acute respiratory viral infection on gut microbiome
What the sources say
- Not checked yetcites [18] Domínguez-Cherit, 2009, Critically Ill patients with 2009 influenza A(H1N1) in Mexico, JAMA source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“antibiotic treatment prior to influenza infection ameliorated the degree of intestinal injury, but not lung injury, suggesting that gut dysbiosis contributed to local but not systemic inflammation”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of acute respiratory viral infection on gut microbiome
What the sources say
- Not checked yetcites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Dysbiosis, or an imbalance in the normal composition of the microbiome, is associated with a variety of chronic diseases, many of which are characterized by chronic inflammation or abnormal metabolism, including inflammatory bowel disease, cardiovascular disease, and diabetes.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“caloric restriction also results in increased relative abundance of Proteobacteria and increased Bacteroidetes to Firmicutes ratio, raising the possibility that decreased oral intake during influenza may contribute to changes in the microbiome”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of acute respiratory viral infection on gut microbiome
What the sources say
- Not checked yetcites [45] Bartley, 2017, Impact of age, caloric restriction, and influenza infection on mouse gut microbiome: an exploratory study of the role of age-related microbiome changes on influenza responses, Front Immunol source
- Not checked yetcites [47] Groves, 2018, Respiratory disease following viral lung infection alters the murine gut microbiota, Front Immunol source
- Not checked yetcites [49] Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature source
- Not checked yetcites [50] Ruiz, 2017, One-year calorie restriction impacts gut microbial composition but not its metabolic performance in obese adolescents, Environ Microbiol source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Macrophages from animals treated with antibiotics exhibited defective responses to type I and II IFNs and impaired capacity to limit viral replication, suggesting that intestinal microbiota provide immune stimulation that establishes an “activation threshold” for innate antiviral immune responses”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
- Not checked yetcites [52] Abt, 2012, Commensal bacteria calibrate the activation threshold of innate antiviral immunity, Immunity source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Mice given a 4 week oral course of broad-spectrum antibiotics before respiratory viral infection mounted an attenuated anti-PR8 antibody response, were incapable of inducing CD4+ T cell-mediated IFN-γ response to PR8 antigen, and had fewer influenza-specific CD8+T cells”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In a murine model of influenza infection, the investigators found that although the total numbers of bacteria in the gut did not decrease, there was a reduction in the quantities of segmented filamentous bacteria (SFB) and Lactobacillus/Lactococcus, accompanied by increases in Enterobacteriaceae.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of acute respiratory viral infection on gut microbiome
What the sources say
- Not checked yetcites [43] Wang, 2014, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation, J Exp Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Short-term perturbations in the gut microenvironment caused by illness, antibiotic usage, or dietary changes (e.g., starvation) can alter the gut microbiome and subsequently lead to transient alterations in immune responses.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
In the paper
“Germ-free mice and antibiotic-treated mice also exhibit impaired antibody responses to seasonal influenza vaccination, which was restored by oral administration of flagellated E. coli, demonstrating a dependence on TLR5-mediated sensing of the host microbiota”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
- Not checked yetcites [53] Oh, 2014, TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination, Immunity source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The respiratory tract is the main site of continuous contact with exogenous microbes.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Skin and oral cavity lineages are represented in the nasopharynx—e.g., Streptococcus, Staphylococcus, Corynebacterium, and Prevotella”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
What the sources say
- Not checked yetcites [70] Charlson, 2011, Topographical continuity of bacterial populations in the healthy human respiratory tract, Am J Respir Crit Care Med source
- Not checked yetcites [72] Ling, 2013, Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates, BMC Genomics source
- Not checked yetcites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Oral administration of a probiotic cocktail containing Lactobacillus restored the immune response and enhanced the activation of signaling pathways associated with recognition of single-stranded RNA virus”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Gut microbiome: therapeutic avenues for acute respiratory infections
What the sources say
- Not checked yetcites [62] Wu, 2013, Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection, Curr Microbiol source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“clinical studies have shown that although probiotics do not influence the incidence of respiratory tract infection, they do reduce the severity of symptoms and duration of the illness”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Gut microbiome: therapeutic avenues for acute respiratory infections
What the sources say
- Not checked yetcites [57] de, 2006, Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial, Vaccine source
- Not checked yetcites [58] Vouloumanou, 2009, Probiotics for the prevention of respiratory tract infections: a systematic review, Int J Antimicrob Agents source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Antibiotic-pretreated animals displayed altered cytokine profiles in the lung compared to untreated controls following S. pneumoniae infection, including significantly decreased TNF-α levels at 6 and 24 h after infection.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
- Not checked yetcites [55] Schuijt, 2016, The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia, Gut source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“animals fed a high fiber diet had increased generation of SCFAs, leading to enhanced antiviral CD8+ T cell immune responses and attenuated neutrophil-mediated lung injury during influenza infection, resulting in improved survival”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Gut microbiome: therapeutic avenues for acute respiratory infections
What the sources say
- Not checked yetcites [63] Trompette, 2018, Dietary fiber confers protection against flu by shaping Ly6c- patrolling monocyte hematopoiesis and CD8+ T cell metabolism, Immunity source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The oropharynx contains members of Firmicutes, Proteobacteria, and Bacteroidetes, including Streptococcus, Neisseria, Haemophilus, and Lachnospira spp.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
What the sources say
- Not checked yetcites [68] Lemon, 2010, Comparative analyses of the bacterial microbiota of the human nostril and oropharynx, MBio source
- Not checked yetcites [70] Charlson, 2011, Topographical continuity of bacterial populations in the healthy human respiratory tract, Am J Respir Crit Care Med source
- Not checked yetcites [71] Yi, 2014, Profiling bacterial community in upper respiratory tracts, BMC Infect Dis source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“In healthy adults, bacteria present in the nasal cavity are typically those associated with skin, predominantly members of the Actinobacteria (e.g., Corynebacterium spp., Propionibacterium spp.), followed by Firmicutes (e.g., Staphylococcus spp.), and Proteobacteria”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
What the sources say
- Not checked yetcites [67] Frank, 2010, The human nasal microbiota and Staphylococcus aureus carriage, PLoS ONE source
- Not checked yetcites [68] Lemon, 2010, Comparative analyses of the bacterial microbiota of the human nostril and oropharynx, MBio source
- Not checked yetcites [69] Bassis, 2014, The nasal cavity microbiota of healthy adults, Microbiome source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“oral administration of Lactobacillus plantarum enhanced the type I IFN response and lowered viral titers in the lungs in a murine model of influenza infection”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Gut microbiome: therapeutic avenues for acute respiratory infections
What the sources say
- Not checked yetcites [60] Maeda, 2009, Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice, Int Immunopharmacol source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Antibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Gut microbiome: therapeutic avenues for acute respiratory infections
What the sources say
- Not checked yetcites [59] Steed, 2017, The microbial metabolite desaminotyrosine protects from influenza through type I interferon, Science source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“microbiome depletion led to decreased survival, increased lung bacterial burden, and increased systemic dissemination of bacteria”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
- Not checked yetcites [55] Schuijt, 2016, The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia, Gut source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Several factors are known to influence airway microbiome composition including infection history, age, genetics, and structural lung disease.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“SFB-deficient animals have increased lung bacterial burdens and more severe pneumonia when challenged with methicillin-resistant Staphylococcus aureus (MRSA) (54), which was associated with decreased IL-17-mediated responses in the lung.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
- Not checked yetcites [54] Gauguet, 2015, Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia, Infect Immun source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“in the microbiota-depleted group, alveolar macrophages and blood neutrophils exhibited decreased phagocytic activity, and decreased inflammatory cytokine production following ex vivo stimulation by Toll-like receptor (TLR) ligands such as lipoteichoic acid (LTA)”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The gut microbiome and respiratory infections > Effects of gut microbiome on host immune responses
What the sources say
- Not checked yetcites [55] Schuijt, 2016, The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia, Gut source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The URT and LRT have similar microbial community compositions, although microbe densities are much higher in the former in healthy hosts.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Individuals with chronic airway diseases (e.g., cystic fibrosis, COPD) have increased bacterial populations in the lungs (77) and differences in the relative abundance of certain species”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The major phyla in healthy lungs are Bacteroidetes and Firmicutes, which mainly include Prevotella, Veillonella, and Streptococcus”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
What the sources say
- Not checked yetcites [78] Morris, 2013, Comparison of the respiratory microbiome in healthy nonsmokers and smokers, Am J Respir Crit Care Med source
- Not checked yetcites [79] Segal, 2013, Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation, Microbiome source
- Not checked yetcites [80] Dickson, 2015, Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography, Ann Am Thorac Soc source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Contrary to dogma that normal healthy lungs are a sterile environment, a distinct, and somewhat dynamic lung microbiome can be identified using sequencing technology, with microaspiration serving as the primary route of microbial immigration from the URT to the LRT”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
What the sources say
- Not checked yetcites [76] Bassis, 2015, Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals, MBio source
- Not checked yetcites [77] Venkataraman, 2015, Application of a neutral community model to assess structuring of the human lung microbiome, MBio source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A limited number of pathogens including Streptococcus pneumoniae, Neisseria meningitides, and Haemophilus influenzae are commensal bacteria of the URT.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Both studies included subjects ranging from infants to adults >80 years of age, limiting conclusions about age-related effects.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [71] Yi, 2014, Profiling bacterial community in upper respiratory tracts, BMC Infect Dis source
- Not checked yetcites [100] Edouard, 2018, The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens, Eur J Clin Microbiol Infect Dis source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, unlike other diseases where decreased diversity is considered deleterious to the host, the effects of viral infections on diversity per se are variable and not presently considered a good indicator of risk for complications, including secondary bacterial pneumonias.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Children with severe influenza showed decreased relative abundance of S. aureus and increased abundance of Prevotella, Streptobacillus, Porphyromonas, Granulicatella, Veillonella, Fusobacterium, and Haemophilus.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [105] Langevin, 2017, Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study, J Gen Virol source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“RSV-infected mice who underwent antibiotic-mediated depletion of Streptococcus viridans in the nasopharynx exhibited increases in number of inflammatory lymphocytes and airway hyperresponsiveness, and decreases in regulatory T cell number and transforming growth factor-β production”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [103] Ni, 2012, Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection, PLoS ONE source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In a study of mice colonized with S. pneumoniae and then infected with influenza A virus 3 days after, S. pneumoniae transmission occurred only when all mice were infected with influenza and was blocked by an influenza-neutralizing antibody”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [95] Diavatopoulos, 2010, Influenza A virus facilitates Streptococcus pneumoniae transmission and disease, FASEB J source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In healthy children, the major phyla among nasopharyngeal microbiotas are Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria, and Fusobacteria, with Moraxella, Haemophilus, Streptococcus, Flavobacteria, Dolosigranulum, Corynebacterium, and Neisseria as predominant genera.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [114] Bogaert, 2011, Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis, PLoS ONE source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Another complicating factor particularly in cross-sectional studies examining the microbiome during viral infections is that the groups are not well-controlled and the sample numbers are relatively small considering the number of variables that could affect the respiratory tract microbiome–such as age, gender, oral hygiene and nose-picking habits, healthcare-based employment status, smoking status”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“although mean relative abundances of Haemophilus, Moraxella, Staphylococcus, and Corynebacterium varied significantly between summer and fall samples and between age groups.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [115] Pérez-Losada, 2017, Nasopharyngeal microbiome diversity changes over time in children with asthma, PLoS ONE source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The underlying type of viral infection, sampling timepoint after onset of infection, severity of infection, and concomittant antimicrobial usage are other confounding factors.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, these studies demonstrated that there was considerable inter-subject variability, highlighting the need for longitudinal studies to decipher changes following viral infection.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [108] Leung, 2013, Modulation of potential respiratory pathogens by pH1N1 viral infection, Clin Microbiol Infect source
- Not checked yetcites [109] Chaban, 2013, Characterization of the upper respiratory tract microbiomes of patients with pandemic H1N1 influenza, PLoS ONE source
- Not checked yetcites [110] Greninger, 2010, A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America, PLoS ONE source
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“An investigation of the frequency and seasonal variation in bacterial and viral load in asymptomatic healthcare professionals during the winter and summer months showed that of the 100 subjects tested during the winter, 34 were colonized with at least one bacterial species and 11 tested positive for at least one virus.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [116] Hassoun, 2015, Seasonal variation of respiratory pathogen colonization in asymptomatic health care professionals: A single-center, cross-sectional, 2-season observational study, Am J Infect Control source
Strength:plain· not yet calibratedn = 100Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In the nasopharyngeal compartment of Aboriginal and non-Aboriginal children in Australia, positive associations were detected between hRV and S. pneumoniae, H. influenza, and Moraxella catarrhalis carriage as well as between adenovirus and M. catarrhalis (111).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [111] Jacoby, 2007, Kalgoorlie Otitis Media Research Project Team. Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract, Vaccine source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“These profiles, however, were not associated with virus type but were linked to the age of subjects (71).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [71] Yi, 2014, Profiling bacterial community in upper respiratory tracts, BMC Infect Dis source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Changes in nasopharyngeal microbiome diversity were observed across seasons, with a predominance of Proteobacteria and Fusobacteria in fall-winter and Bacteroidetes and Firmicutes in spring; these differences were independent of recent antibiotics and viral co-infection (114).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [114] Bogaert, 2011, Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis, PLoS ONE source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In a mouse model, bacterial density in the nasopharynx after LAIV administration was increased as much as 100,000 times compared to influenza-naive hosts, and the duration of carriage of S. pneumoniae or S. aureus was also increased 2 to 5-fold (121).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [121] Mina, 2014, Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice, MBio source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In healthy adult volunteers, it was demonstrated that intranasal LAIV administration induced an increase in the diversity of the nasopharyngeal microbiome, as well as relative abundances of Staphylococcus and Bacteroides (107).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [107] Tarabichi, 2015, The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles, Microbiome source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Nasopharyngeal sampling showed completely opposite results, with decreased relative abundance of Haemophilus and Neisseria spp., but an increase in the normal nasal commensal, Propionibacterium, in subjects following hRV infection (73).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [73] Allen, 2014, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge, Microbiome source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Administration of live attenuated influenza vaccine (LAIV), which is nasally instilled, to healthy children increased the nasal colonization density of S. pneumoniae in subjects who harbored this bacterium at the time of vaccination, and transiently increased rates of colonization by H. influenza (120).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [120] Thors, 2016, The effects of live attenuated influenza vaccine on nasopharyngeal bacteria in healthy 2 to 4 year olds. a randomized controlled trial, Am J Respir Crit Care Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In contrast, of the 100 subjects tested during the summer, 37 harbored at least one bacterium (mainly MRSA and K. pneumoniae) and four tested positive for one virus (116).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [116] Hassoun, 2015, Seasonal variation of respiratory pathogen colonization in asymptomatic health care professionals: A single-center, cross-sectional, 2-season observational study, Am J Infect Control source
Strength:plain· not yet calibratedn = 100Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In the oropharyngeal compartment, rhinovirus infection was associated with a strong trend toward transient increases in the relative abundances of H. parainfluenzae, Neisseria subflava and a weak trend toward an increase in S. aureus (119).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [119] Hofstra, 2015, Changes in microbiota during experimental human Rhinovirus infection, BMC Infect Dis source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Another study of 31 families with small children using longitudinal nasal swab sampling demonstrated that rhinovirus infection was associated with increased acquisition of S. pneumoniae from the community as well as increased transmission of S. pneumoniae within the family (118).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [118] Karppinen, 2017, Acquisition and transmission of streptococcus pneumoniae are facilitated during rhinovirus infection in families with children, Am J Respir Crit Care Med source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Interestingly, the percentage of colonized children and bacterial density were also higher at asymptomatic visits in which virus was detected than at those in which virus was not detected (117).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [117] DeMuri, 2018, Dynamics of bacterial colonization with streptococcus pneumoniae, haemophilus influenzae, and moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection, Clin Infect Dis source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In subjects with chronic obstructive pulmonary disease (COPD) after hRV infection but not in healthy individuals, there was an increase in bacterial burden and growth of bacteria present at baseline, particularly H. influenzae (124).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the LRT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [124] Molyneaux, 2013, Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease, Am J Respir Crit Care Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“First, mucus production in the respiratory tract is increased to facilitate viral clearance during infections. However, excessive mucus production can lead to airway obstruction by impeding mucociliary clearance (125).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the LRT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [125] Vareille, 2011, The airway epithelium: soldier in the fight against respiratory viruses, Clin Microbiol Rev source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Increased upper respiratory tract persistence of S. aureus as well as increased risk of S. aureus pneumonia was observed in flu-infected wildtype mice compared to mice lacking the type III IFN receptor (123).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the URT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [123] Planet, 2016, Lambda interferon restructures the nasal microbiome and increases susceptibility to staphylococcus aureus superinfection, MBio source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Respiratory viruses not only alter the bacterial community in the URT, but also promote bacterial colonization of the LRT by a variety of mechanisms that impair bacterial clearance.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the LRT microbiome during respiratory viral infection
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Compared to studies of the URT microbiome, studies of the LRT microbiome following viral infections are relatively scarce due to the difficulty of obtaining uncontaminated samples from the lung.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the LRT microbiome during respiratory viral infection
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Second, viral infections can also reduce ciliary beat frequency and the number of ciliated cells, disrupt the coordinated movement of cilia, and impede the repair of respiratory epithelial cells, further leading to reduced mucociliary clearance (126, 127).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the LRT microbiome during respiratory viral infection
What the sources say
- Not checked yetcites [126] Pittet, 2010, Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae, Am J Respir Cell Mol Biol source
- Not checked yetcites [127] Smith, 2014, Ciliary dyskinesia is an early feature of respiratory syncytial virus infection, Eur Respir J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Samples of convenience, such as sputum, suffer from oral contamination, but bronchoscopic samples are invasive and expensive to obtain on a regular basis.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > The respiratory tract microbiome > Studies of the LRT microbiome during respiratory viral infection
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Subsequent studies by another group reported that C. pseudodiphtheriticum inhibited S. aureus growth, whereas C. accolens and S. aureus appeared to support each other's growth (139).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Intermicrobial interactions and postviral secondary infections
What the sources say
- Not checked yetcites [139] Yan, 2013, Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage, Cell Host Microbe source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“These data imply that influenza infection perturbs the respiratory microbiome, leading to the production of secondary metabolites including immune-modulating molecules.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Intermicrobial interactions and postviral secondary infections
What the sources say
- Not checked yetcites [108] Leung, 2013, Modulation of potential respiratory pathogens by pH1N1 viral infection, Clin Microbiol Infect source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Interestingly, a recent preclinical study using a murine model of RSV and S. pneumoniae superinfection employed nasal priming by a C. pseudodiphtheriticum strain to augment host defense against the viral infection, which enhanced clearance of secondary bacterial challenge and reduced lung injury measures (140).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Intermicrobial interactions and postviral secondary infections
What the sources say
- Not checked yetcites [140] Kanmani, 2017, Respiratory commensal bacteria corynebacterium pseudodiphtheriticum improves resistance of infant mice to respiratory syncytial virus and streptococcus pneumoniae superinfection, Front Microbiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Conversely, other investigators observed that Corynebacterium spp. were enriched in children who were not nasally colonized with pneumococcus, and demonstrated that C. accolens inhibit S. pneumoniae growth in vitro by expressing a lipase that releases free fatty acids from skin surface triacylglycerols, which inhibit pneumococcal growth.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Intermicrobial interactions and postviral secondary infections
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The mechanism appeared to be bacteriocin-independent.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Intermicrobial interactions and postviral secondary infections
What the sources say
- Not checked yetcites [137] Uehara, 2000, Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp, J Hosp Infect source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, it is possible that the immune response incited by acute viral infections, changes in the host epithelial surface caused by the virus, or the virus itself might lead to elimination of a host commensal that is responsible for keeping pathobionts in check.”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Intermicrobial interactions and postviral secondary infections
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Rests on an assumption: Interspecies competition maintains homeostasis of the microbial community, preventing one microbe from dominating the community.
None of the sources cited for this claim have been checked yet.
In the paper
“Viruses have also been found to impair bacterial biofilm formation and disrupt existing biofilm (141–144).”
§ Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia > Intermicrobial interactions and postviral secondary infections
What the sources say
- Not checked yetcites [141] Reddinger, 2016, Host physiologic changes induced by influenza a virus lead to staphylococcus aureus biofilm dispersion and transition from asymptomatic colonization to invasive disease, MBio source
- Not checked yetcites [142] Pettigrew, 2014, Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection, Infect Immun source
- Not checked yetcites [143] Marks, 2013, Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease, MBio source
- Not checked yetcites [144] Reddinger, 2018, Streptococcus pneumoniae modulates staphylococcus aureus biofilm dispersion and the transition from colonization to invasive disease, MBio source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
Bacterial pneumonia frequently arises as a result of aspirated bacterial pathogens.
“Given that bacterial pneumonia frequently arises as a result of aspirated bacterial pathogens, a potential mechanism by which viral infections might increase the risk of secondary bacterial infections is through increased colonization of the upper respiratory tract by bacterial pathogens.”
The paper relies on this without support.
Interspecies competition maintains homeostasis of the microbial community, preventing one microbe from dominating the community.
“However, interspecies competition also maintains homeostasis of the microbial community, either through their abilities to capture scare resources (e.g., iron), or targeted killing of other bacteria (e.g., bacteriocins), preventing one microbe from dominating the community.”
The paper relies on this without support.
Mechanisms have evolved in bacteria that confer competitive advantages, permitting them to survive in an otherwise inhospitable host environment.
“It has long been appreciated that mechanisms have evolved in bacteria that confer competitive advantages, permitting them to survive in an otherwise inhospitable host environment.”
The paper relies on this without support.
Innate immune cells including macrophages and neutrophils are recruited to the lung by cytokines and chemokines for phagocytosis and bactericidal activity.
“Innate immune cells including macrophages and neutrophils are recruited to the lung by cytokines and chemokines for phagocytosis and bactericidal activity.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza is the most common type of acute respiratory infection (Hanada et al., 2018)”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Hanada et al., 2018
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
The role of nasal carriage in Staphylococcus aureus infections
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70295-4 · Cited by 2,685
Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic.
Johnson, N. P. A. S., & Mueller, J. (2002) · Bulletin of the History of Medicine · doi:10.1353/bhm.2002.0022 · Cited by 1,980
Streptococcus pneumoniae colonisation: the key to pneumococcal disease
Bogaert, D., de Groot, R., & Hermans, P. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00938-7 · Cited by 1,929 · cited 1×
“Nonetheless, bacterial colonization of the URT is generally considered as the first step in the development of invasive bacterial infections (83, 84), including secondary bacterial infections following respiratory viral infection.”
BackgroundHospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · cited 1×
“It is estimated that the so-called "Spanish Flu" pandemic of H1N1 influenza A virus from 1918 to 1919 resulted in more than 50 million deaths, with many caused by bacterial superinfection leading to secondary pneumonia (1) (2) (3) (4) (5) (6) (7) .”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Zuo, T., Zhang, F., Lui, G. C. Y., Yeoh, Y. K., Li, A. Y. L., Zhan, H., Wan, Y., Chung, A. C. K., Cheung, C. P., Chen, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.048 · Cited by 1,537
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
Dashraath, P., Wong, J. L. J., Lim, M. X. K., Lim, L. M., Li, S. W. L., Biswas, A., Choolani, M. A., Mattar, C. N. Z., & Su, L. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.03.021 · Cited by 1,521
Iddir, M., Alex Brito, O., Dingeo, G., Sosa, S., Samouda, H., Frano, M. R. L., & Bohn, T. (2020) · Nutrients · doi:10.3390/nu12061562 · Cited by 825
Shen, Z., Xiao, Y., Kang, L., Ma, W., Shi, L., Zhang, L., Zhou, Z., Yang, J., Zhong, J., Yang, D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa203 · Cited by 513
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 571
The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases
Zhang, D., Li, S., Wang, N., Tan, H., Zhang, Z., & Feng, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00301 · Cited by 453
Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
Guo, L., Wei, D., Zhang, X., Wu, Y., Li, Q. Y., Zhou, M., & Qu, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02752 · Cited by 412
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
Violi, F., Cammisotto, V., Bartimoccia, S., Pignatelli, P., Carnevale, R., & Nocella, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00737-2 · Cited by 400
Sencio, V., Machado, M. G., & Trottein, F. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-00361-8 · Cited by 322
Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
Guo, M., Tao, W., Flavell, R. A., & Zhu, S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00416-6 · Cited by 314
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Gasmi, A., Noor, S., Tippairote, T., Dadar, M., Menzel, A., & Bjørklund, G. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108409 · Cited by 316
Bacterial co‐infections with SARS‐CoV ‐2
Mirzaei, R., Goodarzi, P., Asadi, M., Soltani, A., Aljanabi, H. A. A., Jeda, A. S., Dashtbin, S., Jalalifar, S., Mohammadzadeh, R., Teimoori, A., et al. (2020) · IUBMB Life · doi:10.1002/iub.2356 · Cited by 306
Lucien, M. A. B., Canarie, M. F., Kilgore, P. E., Jean-Denis, G., Fénélon, N., Pierre, M., Cerpa, M., Joseph, G., Maki, G., Zervos, M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.087 · Cited by 267
Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic
Baud, D., Dimopoulou Agri, V., Gibson, G. R., Reid, G., & Giannoni, E. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00186 · Cited by 240
Microbiota Modulation of the Gut-Lung Axis in COVID-19
de Oliveira, G. L. V., Oliveira, C. N. S., Pinzan, C. F., de Salis, L. V. V., & Cardoso, C. R. D. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635471 · Cited by 242
Melatonin: Roles in influenza, Covid‐19, and other viral infections
Anderson, G., & Reiter, R. J. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2109 · Cited by 212
Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence
Groves, H., Higham, S. L., Moffatt, M. F., Cox, M. J., & Tregoning, J. S. (2020) · mBio · doi:10.1128/mbio.03236-19 · Cited by 223
Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
Bao, L., Zhang, C., Dong, J., Zhao, L., Li, Y., & Sun, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01840 · Cited by 207
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
Al-Kuraishy, H. M., Al-Gareeb, A. I., Al-Hussaniy, H. A., Al-Harcan, N. A. H., Alexiou, A. T., & Batiha, G. E. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108516 · Cited by 201
Sun, Z., Song, Z., Liu, C., Tan, S., Lin, S., Zhu, J., Dai, F., Gao, J., She, J.-L., Mei, Z., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02212-0 · Cited by 173
Tang, L., Gu, S., Gong, Y., Li, B., Lu, H., Li, Q., Zhang, R., Gao, X., Wu, Z., Zhang, J., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.05.013 · Cited by 169
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results
Caruana, G., Croxatto, A., Coste, A. T., Opota, O., Lamoth, F., Jaton, K., & Greub, G. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.019 · Cited by 162
Gut-lung axis and dysbiosis in COVID-19
Aktaş, B., & Aslım, B. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2005-102 · Cited by 170
The human microbiome and COVID-19: A systematic review
Yamamoto, S., Saito, M., Tamura, A., Prawisuda, D., Mizutani, T., & Yotsuyanagi, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253293 · Cited by 148
Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases
Saint‐Criq, V., Lugo‐Villarino, G., & Thomas, M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101235 · Cited by 152
Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
Ahlawat, S., Asha, A., & Sharma, K. K. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198103 · Cited by 137
Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection
He, L., Ren, L., Li, J., Wu, Y.-N., Li, X., & Zhang, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01388 · Cited by 135
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
Peng, X., Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Zhu, B., & Routy, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.596631 · Cited by 126
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
Maio, F. D., Posteraro, B., Ponziani, F. R., Cattani, P., Gasbarrini, A., & Sanguinetti, M. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00131-7 · Cited by 116
Faecalibacterium prausnitzii: A Next-Generation Probiotic in Gut Disease Improvement
He, X., Zhao, S., & Li, Y. (2021) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2021/6666114 · Cited by 130
Assefa, M. (2022) · Pneumonia · doi:10.1186/s41479-022-00096-z · Cited by 115
Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons
Oliva, J., & Terrier, O. (2021) · Viruses · doi:10.3390/v13091725 · Cited by 113
Inhalable MOF‐Derived Nanoparticles for Sonodynamic Therapy of Bacterial Pneumonia
Pan, X., Wu, N., Tian, S., Guo, J., Wang, C., Sun, Y., Huang, Z., Chen, F., Wu, Q., Jing, Y., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202112145 · Cited by 104
Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications
Khatiwada, S., & Subedi, A. (2020) · Human Microbiome Journal · doi:10.1016/j.humic.2020.100073 · Cited by 105
Potempa, L. A., Rajab, I. M., Hart, P. C., Bordón, J., & Fernandez-Botrán, R. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0473 · Cited by 105
Yang, A., Chen, C., Hu, Y., Zheng, G., Chen, P., Xie, Z., Fan, H., Sun, Y., Wu, P., Jiang, W., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01488-22 · Cited by 101
Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders
Shahbazi, R., Yasavoli‐Sharahi, H., Alsadi, N., Ismail, N., & Matar, C. (2020) · Molecules · doi:10.3390/molecules25214891 · Cited by 102
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19
Li, M., Ren, L., Wang, Y., Zhong, J., Zhang, D., Xiao, Y., Li, J., Yang, J., Fan, G., Guo, L., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202103-0814oc · Cited by 99
Endotoxemia and circulating bacteriome in severe COVID-19 patients
Sirivongrangson, P., Kulvichit, W., Payungporn, S., Pisitkun, T., Chindamporn, A., Peerapornratana, S., Pisitkun, P., Chitcharoen, S., Sawaswong, V., Worasilchai, N., et al. (2020) · Intensive Care Medicine Experimental · doi:10.1186/s40635-020-00362-8 · Cited by 98
Manohar, P., Loh, B., Athira, S., Nachimuthu, R., Hua, X., Welburn, S. C., & Leptihn, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01434 · Cited by 95
Horn, K. J., Schopper, M. A., Drigot, Z., & Clark, S. E. (2022) · Nature Communications · doi:10.1038/s41467-022-31074-0 · Cited by 97
Zhang, H., Ai, J., Yang, W., Zhou, X., He, F., Xie, S., Zeng, W., Li, Y., Yu, Y., Gou, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa663 · Cited by 92
The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
Fakharian, F., Thirugnanam, S., Welsh, D. A., Kim, W., Rappaport, J., Bittinger, K. L., & Rout, N. (2023) · Microorganisms · doi:10.3390/microorganisms11071849 · Cited by 107
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases
Kamel, M. S., Aleya, S., Alsubih, M., & Aleya, L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020217 · Cited by 99
The impact of lung microbiota dysbiosis on inflammation
Yang, D., Xing, Y., Song, X., & Qian, Y. (2019) · Immunology · doi:10.1111/imm.13139 · Cited by 100
Qu, J., Cai, Z., Liu, Y., Duan, X., Han, S., Liu, J., Zhu, Y., Jiang, Z., Zhang, Y., Zhuo, C., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.641920 · Cited by 87
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects
Kurian, S. J., Unnikrishnan, M. K., Miraj, S. S., Bagchi, D., Banerjee, M., Reddy, B. S., Rodrigues, G. S., Manu, M. K., Saravu, K., Mukhopadhyay, C., et al. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.03.002 · Cited by 95
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi, F., Tortora, C., Argenziano, M., Paola, A. D., & Punzo, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113809 · Cited by 83
Hypoxia: The “Invisible Pusher” of Gut Microbiota
Han, N., Pan, Z., Liu, G., Yang, R., & Bi, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.690600 · Cited by 80
Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease
Zhou, A., Lei, Y., Tang, L., Hu, S., Yang, M., Wu, L., Yang, S., & Tang, B. (2020) · Journal of Bacteriology · doi:10.1128/jb.00454-20 · Cited by 80
Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential
Hussain, I., Cher, G. L. Y., Abid, M. A., & Abid, M. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765965 · Cited by 75
Breath analysis for detection of viral infection, the current position of the field
Gould, O., Ratcliffe, N. A., Król, E., & Costello, B. D. L. (2020) · Journal of Breath Research · doi:10.1088/1752-7163/ab9c32 · Cited by 72
Gao, M., Wang, H., Luo, H., Sun, Y., Wang, L., Ding, S., Ren, H., Gang, J., Rao, B., Liu, S., et al. (2021) · Advanced Science · doi:10.1002/advs.202102785 · Cited by 73
Liu, F., Ye, S., Zhu, X. J., He, X., Wang, S., Li, Y., Lin, J., Wang, J., Lin, Y., Ren, X., et al. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02583-7 · Cited by 70
The find of COVID-19 vaccine: Challenges and opportunities
ElBagoury, M., Tolba, M. M., Nasser, H. A., Jabbar, A., Elagouz, A. M., Aktham, Y., & Hutchinson, A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.12.025 · Cited by 71
PASCALE, G. D., Maio, F. D., Carelli, S., Angelis, G. D., Cacaci, M., Montini, L. M., Bello, G., Cutuli, S. L., Pintaudi, G., Tanzarella, E. S., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03623-4 · Cited by 70
Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19
Walton, G., Gibson, G. R., & Hunter, K. A. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003980 · Cited by 66
Vignesh, R., Swathirajan, C. R., Tun, Z. H., Rameshkumar, M. R., Solomon, S. S., & Balakrishnan, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607734 · Cited by 66
Gupta, A., Karyakarte, R. P., Joshi, S., Das, R., Jani, K., Shouche, Y. S., & Sharma, A. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104880 · Cited by 62
Aguilera, E. R., & Lenz, L. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00105 · Cited by 65
Next-Generation Sequencing Reveals the Progression of COVID-19
Chen, X., Kang, Y., Luo, J., Pang, K., Xu, X. Y., Wu, J., Li, X., & Jin, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.632490 · Cited by 69
Activation of TLR4 by viral glycoproteins: A double-edged sword?
Halajian, E. A., LeBlanc, E. V., Gee, K., & Colpitts, C. C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1007081 · Cited by 66
Microbiota and COVID-19: Long-term and complex influencing factors
Gang, J., Wang, H., Xue, X., & Zhang, S. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.963488 · Cited by 62
Shinde, T., Hansbro, P. M., Sohal, S. S., Dingle, P., Eri, R., & Stanley, R. (2020) · Microorganisms · doi:10.3390/microorganisms8060921 · Cited by 61
Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota
Kaneko, K., Akagawa, S., Akagawa, Y., Kimata, T., & Tsuji, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01616 · Cited by 62
Mullish, B. H., Marchesi, J. R., McDonald, J. A. K., Pass, D. A., Masetti, G., Michael, D. R., Plummer, S. F., Jack, A. A., Davies, T. S., Hughes, T. R., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1900997 · Cited by 61
At the crux of maternal immune activation: Viruses, microglia, microbes, and IL‐17A
Otero, A. M., & Antonson, A. M. (2022) · Immunological Reviews · doi:10.1111/imr.13125 · Cited by 57
Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
Favilli, A., Gentili, M. M., Raspa, F., Giardina, I., Parazzini, F., Vitagliano, A., Borisova, A. V., & Gerli, S. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1774875 · Cited by 57
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
Romani, L., CHIERICO, F. D., Macari, G., Pane, S., Ristori, M. V., Guarrasi, V., Gardini, S., Pascucci, G. R., Cotugno, N., Perno, C. F., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.908492 · Cited by 60
Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia
Alqahtani, A., Alamer, E., Mir, M. A., Alasmari, A., Alshahrani, M. M., Asiri, M., Ahmad, I. S., Alhazmi, A., & Algaissi, A. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042424 · Cited by 57
Shi, T., Wang, J., Dong, J., Hu, P., & Guo, Q. (2023) · Pathogens · doi:10.3390/pathogens12091110 · Cited by 55
Next-Generation Probiotics and Their Metabolites in COVID-19
Gautier, T., Gall‐David, S. L., Sweidan, A., Tamanai‐Shacoori, Z., Jolivet‐Gougeon, A., Loréal, O., & Bousarghin, L. (2021) · Microorganisms · doi:10.3390/microorganisms9050941 · Cited by 59
The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID‐19 Patients
Soltani, S., Zakeri, A., Zandi, M., Kesheh, M. M., Tabibzadeh, A., Dastranj, M., Faramarzi, S., Didehdar, M., Hafezi, H., Hosseini, P., et al. (2021) · BioMed Research International · doi:10.1155/2021/6670798 · Cited by 53
Mucus, Microbiomes and Pulmonary Disease
Meldrum, O. W., & Chotirmall, S. H. (2021) · Biomedicines · doi:10.3390/biomedicines9060675 · Cited by 57
Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study
Slob, E. M. A., Brew, B. K., Vijverberg, S. J. H., Kats, C. J. A. R., Longo, C., Pijnenburg, M. W. H., van Beijsterveldt, T. C. E. M., Dolan, C. V., Bartels, M., Magnusson, P., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02021-2019 · Cited by 53
Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
Almeida, C., Oliveira, R., Baylina, P., Fernandes, R., Teixeira, F. G., & Barata, P. (2022) · Biomedicines · doi:10.3390/biomedicines10112742 · Cited by 52
Hafiz, T. A., Alghamdi, S. S., Mubaraki, M. A., Alghamdi, S. S. M., Alothaybi, A., Aldawood, E., & Alotaibi, F. E. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.01.004 · Cited by 51
Sputum microbiome profiling in COPD: beyond singular pathogen detection
Ditz, B., Christenson, S. A., Rossen, J. W. A., Brightling, C. E., Kerstjens, H. A. M., van den Berge, M., & Faiz, A. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214168 · Cited by 55
Gut microbiome a promising target for management of respiratory diseases
Trivedi, R., & Barve, K. H. (2020) · Biochemical Journal · doi:10.1042/bcj20200426 · Cited by 53
Clinical Implications of Polymicrobial Synergism Effects on Antimicrobial Susceptibility
Little, W., Black, C., & Smith, A. C. (2021) · Pathogens · doi:10.3390/pathogens10020144 · Cited by 49
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
Cyprian, F. S., Sohail, M. U., Abdelhafez, I., Salman, S., Attique, Z., Kamareddine, L., & Al‐Asmakh, M. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.071 · Cited by 50
Cross-talk between immune system and microbiota in COVID-19
Ghavami, S. B., Pourhamzeh, M., Farmani, M., Raftar, S. K. A., Shahrokh, S., Shpichka, A. I., Aghdaei, H. A., Hakemi-Vala, M., Hossein‐Khannazer, N., Timashev, P. S., et al. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1991311 · Cited by 51
Shi, H. Y., Zhu, X., Li, W. L., Mak, J. W. Y., Wong, S. H., Zhu, S. T., Guo, S. L., Chan, F. K. L., Zhang, S. T., & Ng, S. C. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02519-x · Cited by 48
The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury
Zinter, M. S., Lindemans, C. A., Versluys, B. A. B., Mayday, M. Y., Sunshine, S., Reyes, G. A., Sirota, M., Sapru, A., Matthay, M. A., Kharbanda, S., et al. (2020) · Blood · doi:10.1182/blood.2020009246 · Cited by 47
Mohammed, A. K., Alghetaa, H., Miranda, K., Wilson, K. M., Singh, N. P., Cai, G., Putluri, N., Nagarkatti, P. S., & Nagarkatti, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176244 · Cited by 50
Krämer, A., Lexow, F., Bludau, A., Köster, A. M., Misailovski, M., Seifert, U., Eggers, M., Rutala, W. A., Dancer, S. J., & Scheithauer, S. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00186-23 · Cited by 47
Prasad, N., Rhodes, J., Deng, L., McCarthy, N. L., Moline, H. L., Baggs, J. M., Reddy, S. C., Jernigan, J. A., Havers, F. P., Sosin, D. M., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad028 · Cited by 47
Bacterial infections in patients hospitalized with COVID-19
Moreno‐Torres, V., de Mendoza, C., de la Fuente, S., Sánchez, E., Martínez‐Urbistondo, M., Herráiz, J., Gutiérrez, A., Gutiérrez, Á., Hernández, C., Callejas, A., et al. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02824-7 · Cited by 50
Ferreira, C., Viana, S., & Reis, F. (2020) · Microorganisms · doi:10.3390/microorganisms9010053 · Cited by 46
The role of mucosal barriers in disease progression and transmission
Bustos, N. A., Ribbeck, K., & Wagner, C. E. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115008 · Cited by 46
Woehlk, C., von Bülow, A., Ghanizada, M., Soendergaard, M. B., Hansen, S., & Porsbjerg, C. M. (2022) · European Respiratory Journal · doi:10.1183/13993003.00446-2022 · Cited by 49
Little, J. S., Tandon, M., Hong, J., Nadeem, O., Sperling, A. S., Raje, N. S., Munshi, N. C., Frigault, M. J., Barmettler, S., & Hammond, S. P. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010524 · Cited by 44
Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions
Varricchi, G., Poto, R., Ianiro, G., Punziano, A., Marone, G., Gasbarrini, A., & Spadaro, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712915 · Cited by 45
Gao, J., Yan, Y., Gao, S., Li, H., Li, H., Cheng, J., Hu, Y., Cai, K., Zhang, X., & Li, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.11.009 · Cited by 43
Patra, S., Saxena, S., Sahu, N., Pradhan, B., & Roychowdhury, A. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09748-w · Cited by 43
Hoang, V. T., Dao, T.-L., Ly, T. D. A., Belhouchat, K., Chaht, K. L., Gaudart, J., Mrenda, B. M., Drali, T., Yezli, S., Alotaibi, B., et al. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1693247 · Cited by 42
The Interplay between the Host Microbiome and Pathogenic Viral Infections
González, R., & Elena, S. F. (2021) · mBio · doi:10.1128/mbio.02496-21 · Cited by 47
Smart responsive materials for antibacterial therapy: Progress, opportunities, and challenges
Fu, J., Wang, C., Liu, X., Zhu, S., Zheng, Y., Li, Z., Cui, Z., Zhang, Y., Jiang, H., Cao, Y., et al. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2025.101532 · Cited by 43
Lan, X.-F., Olaleye, O. E., Lu, J.-L., Yang, W., Du, F., Yang, J., Cheng, C., Shi, Y.-H., Wang, F., Zeng, X.-S., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00651-2 · Cited by 41
The internationalization of human microbiome research
Porras, A. M., & Brito, I. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.09.012 · Cited by 41
Metadata
- Authors
- Hanada, S., Pirzadeh, M., Carver, K. Y., & Deng, J. C.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Deng, Jane C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-11-16
- Volume
- 9
- Pages
- 2640-2640
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC6250824
- OpenAlex
- W2900850632
- Semantic Scholar
- 8c97d3d01a4d77e5f4f458ed46ba5399f3647a74
- Cited by
- 495
- References
- 147
- Citations by year
- 2026: 29 · 2025: 53 · 2024: 58 · 2023: 77 · 2022: 89 · 2021: 110 · 2020: 72 · 2019: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL108949)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- respiratory viral infections, influenza, secondary bacterial pneumonia, airway microbiome, dysbiosis, gut microbiota, mucosal microbiota, host defense, viral-bacterial interactions, antiviral immunity
- MeSH terms
- Gastrointestinal Microbiome, Host Microbial Interactions, Humans, Immunity, Innate, Respiratory Tract Infections, Virus Diseases, Pneumonia, Bacterial, Coinfection, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review